Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

62.40
-0.4600-0.73%
Post-market: 62.510.1100+0.18%18:35 EDT
Volume:15.87M
Turnover:998.88M
Market Cap:127.03B
PE:13.74
High:64.13
Open:63.28
Low:62.40
Close:62.86
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:1.11
T/O Rate:0.78%
Dividend:2.51
Dividend Rate:4.02%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:5.69
PE(LYR):18.03

Loading ...

Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 24

Biokin Pharma Triggers Second $250 Million Milestone from Bristol Myers Squibb Deal; Shares Down 4%

MT Newswires Live
·
Sep 22

Travere Therapeutics Names Bradley Campbell CEO, Effective Dec. 1, 2026

Reuters
·
Sep 22

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 21

Sichuan Biokin Pharmaceutical Says Unit Received $250 Mln Milestone Payment from Bristol-Myers Squibb for Iza-Bren Agreement

THOMSON REUTERS
·
Sep 21

Bloomsbury Publishing (BMY) Gets a Buy from Berenberg Bank

TIPRANKS
·
Sep 18

Bristol Myers Squibb to Report Q3 Results, Host Earnings Call

Reuters
·
Sep 18

Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026

THOMSON REUTERS
·
Sep 18

Bristol-Myers Squibb Announces R$ 2.15-Per-Unit Dividend for Q4 2026

Reuters
·
Sep 18

Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 18

Bristol Myers Squibb Reports Sustained Sotyktu Responses in Psoriatic Arthritis Through 2 Years

MT Newswires Live
·
Sep 17

Bristol Myers Squibb Presents Sotyktu (Deucravacitinib) Data Showing Durable Efficacy, Consistent Safety in Adults with Psoriatic Arthritis over Two Years

THOMSON REUTERS
·
Sep 17

Bristol-Myers Squibb Company - Sotyktu Well-Tolerated Through Week 104 with no New Safety Signals

THOMSON REUTERS
·
Sep 17

Bristol-Myers Squibb Price Target Raised to $82.00/Share from $75.00 by Piper Sandler

Dow Jones
·
Sep 17

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 16

Bristol-Myers Squibb (BMY) Receives a Buy from Piper Sandler

TIPRANKS
·
Sep 16

Bristol-Myers Squibb Keeps Quarterly Dividend at $0.63 a Share, Payable Nov. 2 to Shareholders of Record on Oct. 2

MT Newswires Live
·
Sep 16

Bristol Myers Squibb Announces Dividend

THOMSON REUTERS
·
Sep 16

Piper Sandler Adjusts PT on Bristol-Myers Squibb to $82 From $75, Keeps Overweight Rating

MT Newswires Live
·
Sep 16

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

Reuters
·
Sep 16